JP2008543331A - イヌ細胞中でウイルスのネガティブセンスrnaを発現する方法および組成物 - Google Patents
イヌ細胞中でウイルスのネガティブセンスrnaを発現する方法および組成物 Download PDFInfo
- Publication number
- JP2008543331A JP2008543331A JP2008518287A JP2008518287A JP2008543331A JP 2008543331 A JP2008543331 A JP 2008543331A JP 2008518287 A JP2008518287 A JP 2008518287A JP 2008518287 A JP2008518287 A JP 2008518287A JP 2008543331 A JP2008543331 A JP 2008543331A
- Authority
- JP
- Japan
- Prior art keywords
- virus
- influenza
- cells
- rna
- canine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1241—Nucleotidyltransferases (2.7.7)
- C12N9/1247—DNA-directed RNA polymerase (2.7.7.6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
- C12N2510/02—Cells for production
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16211—Influenzavirus B, i.e. influenza B virus
- C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Plant Pathology (AREA)
- Analytical Chemistry (AREA)
- Pulmonology (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US69297805P | 2005-06-21 | 2005-06-21 | |
US69296505P | 2005-06-21 | 2005-06-21 | |
US69955505P | 2005-07-15 | 2005-07-15 | |
US69955605P | 2005-07-15 | 2005-07-15 | |
US70200605P | 2005-07-22 | 2005-07-22 | |
US79352506P | 2006-04-19 | 2006-04-19 | |
US79352206P | 2006-04-19 | 2006-04-19 | |
PCT/US2006/023867 WO2007002008A2 (en) | 2005-06-21 | 2006-06-20 | Methods and compositions for expressing negative-sense viral rna in canine cells |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2008543331A true JP2008543331A (ja) | 2008-12-04 |
Family
ID=37595721
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2008518287A Pending JP2008543331A (ja) | 2005-06-21 | 2006-06-20 | イヌ細胞中でウイルスのネガティブセンスrnaを発現する方法および組成物 |
JP2008518286A Pending JP2008546408A (ja) | 2005-06-21 | 2006-06-20 | 異種プロテアーゼを発現させるための方法および組成物 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2008518286A Pending JP2008546408A (ja) | 2005-06-21 | 2006-06-20 | 異種プロテアーゼを発現させるための方法および組成物 |
Country Status (11)
Country | Link |
---|---|
US (4) | US20060286591A1 (ru) |
EP (2) | EP1917352A4 (ru) |
JP (2) | JP2008543331A (ru) |
KR (2) | KR20080025171A (ru) |
AU (2) | AU2006262381A1 (ru) |
BR (1) | BRPI0612268A2 (ru) |
CA (2) | CA2613284A1 (ru) |
IL (1) | IL188202A0 (ru) |
NO (1) | NO20080358L (ru) |
RU (1) | RU2008101367A (ru) |
WO (2) | WO2007002007A2 (ru) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2012527228A (ja) * | 2009-05-21 | 2012-11-08 | ノバルティス アーゲー | 非内因性polIプロモーターを使用した逆遺伝学 |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7763609B2 (en) | 2003-12-15 | 2010-07-27 | Schering Corporation | Heterocyclic aspartyl protease inhibitors |
US7959929B2 (en) * | 2005-04-21 | 2011-06-14 | University Of Florida Research Foundation, Inc. | Materials and methods for respiratory disease control in canines |
US11865172B2 (en) | 2005-04-21 | 2024-01-09 | University Of Florida Research Foundation, Inc. | Materials and methods for respiratory disease control in canines |
EP1917352A4 (en) | 2005-06-21 | 2009-03-25 | Medimmune Vaccines Inc | METHODS AND COMPOSITIONS FOR EXPRESSING HETEROLOGOUS PROTEASE |
US7790434B2 (en) | 2005-06-21 | 2010-09-07 | Medimmune, Llc | Methods and compositions for expressing negative-sense viral RNA in canine cells |
US7682619B2 (en) | 2006-04-06 | 2010-03-23 | Cornell Research Foundation, Inc. | Canine influenza virus |
JP5491173B2 (ja) * | 2006-04-19 | 2014-05-14 | メディミューン,エルエルシー | イヌ細胞中でマイナス鎖ウイルスrnaを発現させるための方法および組成物 |
EP3456348A1 (en) | 2006-09-11 | 2019-03-20 | Seqirus UK Limited | Making influenza virus vaccines without using eggs |
US9163053B2 (en) * | 2007-05-18 | 2015-10-20 | Fluidigm Corporation | Nucleotide analogs |
JP5540329B2 (ja) | 2007-06-26 | 2014-07-02 | 公益財団法人ヒューマンサイエンス振興財団 | 高リスク群ヒトパピローマウイルスに対する交差性中和抗体を誘導するワクチン抗原 |
GB0810305D0 (en) | 2008-06-05 | 2008-07-09 | Novartis Ag | Influenza vaccination |
KR20110074563A (ko) | 2008-09-24 | 2011-06-30 | 메디뮨 엘엘씨 | 바이러스의 정제 방법 |
KR20120027276A (ko) | 2009-04-27 | 2012-03-21 | 노파르티스 아게 | 인플루엔자를 예방하기 위한 면역증강된 백신 |
AU2010277310B2 (en) | 2009-07-31 | 2015-01-15 | Seqirus UK Limited | Reverse genetics systems |
CN102220437B (zh) * | 2011-04-27 | 2014-04-23 | 贵州省烟草科学研究所 | 部分接种鉴定烟草病毒病抗性的方法 |
EP2820126B1 (en) | 2012-03-02 | 2017-05-17 | Seqirus UK Limited | Influenza virus reassortment |
GB201220119D0 (en) * | 2012-11-08 | 2012-12-26 | Univ Cork | Vector |
EP2925356A2 (en) | 2012-12-03 | 2015-10-07 | Novartis AG | Reassortant influenza a viren |
MX2015011529A (es) | 2013-03-13 | 2016-02-05 | Novartis Ag | Reordenamiento del virus de infuenza b. |
DE202013005130U1 (de) | 2013-06-05 | 2013-09-10 | Novartis Ag | Influenza Virus Reassortierung |
DE202013005100U1 (de) | 2013-06-05 | 2013-08-26 | Novartis Ag | Influenza Virus Reassortierung |
AU2014276418A1 (en) | 2013-06-06 | 2016-01-21 | Novartis Ag | Influenza virus reassortment |
US9616114B1 (en) | 2014-09-18 | 2017-04-11 | David Gordon Bermudes | Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity |
JP6748067B2 (ja) * | 2015-03-17 | 2020-08-26 | 一般財団法人阪大微生物病研究会 | インフルエンザウイルス作出用細胞 |
CN106520700B (zh) * | 2016-11-10 | 2019-12-27 | 中国食品药品检定研究院 | 稳定表达牛胰蛋白酶原的mdck细胞系及其用途 |
US11129906B1 (en) | 2016-12-07 | 2021-09-28 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
US11180535B1 (en) | 2016-12-07 | 2021-11-23 | David Gordon Bermudes | Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria |
WO2020004425A1 (ja) * | 2018-06-27 | 2020-01-02 | 一般財団法人阪大微生物病研究会 | インフルエンザウイルスの培養方法 |
CN109762938B (zh) * | 2019-02-01 | 2022-06-10 | 中国水产科学研究院珠江水产研究所 | 用于区分鳜鱼弹状病毒vRNA、cRNA和mRNA的引物组合及试剂盒 |
CN109652384B (zh) * | 2019-02-21 | 2021-10-26 | 昆明理工大学 | 一种体外培养戊型肝炎病毒的方法 |
BR102020010208A2 (pt) | 2020-05-21 | 2022-04-12 | Fundação Oswaldo Cruz | Construção de ácido nucleico, virus influenza recombinante, método para preparar um virus influenza recombinante, composição, e, uso. |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003091401A2 (en) * | 2002-04-26 | 2003-11-06 | Medimmune Vaccines, Inc. | Multi plasmid system for the production of influenza virus |
WO2004078912A2 (fr) * | 2003-02-28 | 2004-09-16 | Institut Pasteur | Promoteur de l’arn polymerase i de poulet et son utilisation |
Family Cites Families (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6001634A (en) * | 1989-08-28 | 1999-12-14 | Palese; Peter | Recombinant negative strand RNA viruses |
US6887699B1 (en) * | 1990-05-22 | 2005-05-03 | Medimmune Vaccines, Inc. | Recombinant negative strand RNA virus expression systems and vaccines |
US6348327B1 (en) * | 1991-12-06 | 2002-02-19 | Genentech, Inc. | Non-endocrine animal host cells capable of expressing variant proinsulin and processing the same to form active, mature insulin and methods of culturing such cells |
ES2210273T5 (es) | 1994-07-18 | 2010-03-29 | Conzelmann, Karl-Klaus, Prof. Dr. | Virus con arn de cadena negativa no segmentado recombinante infeccioso. |
FR2723104B1 (fr) * | 1994-07-27 | 1996-09-13 | Rhone Poulenc Rorer Sa | Nouvelle topoisomerase iv, sequences nucleotiques correspondantes et leurs utilisations |
US5824536A (en) * | 1994-08-23 | 1998-10-20 | St. Jude Children's Research Hospital | Influenza virus replicated in mammalian cell culture and vaccine production |
WO1996010400A1 (en) * | 1994-09-30 | 1996-04-11 | The Uab Research Foundation | Gene therapy vectors and vaccines based on non-segmented negatives stranded rna viruses |
US5753489A (en) * | 1994-11-10 | 1998-05-19 | Immuno Ag | Method for producing viruses and vaccines in serum-free culture |
WO1996015232A1 (en) | 1994-11-16 | 1996-05-23 | St. Jude Children's Research Hospital | Novel replication process |
US7153510B1 (en) | 1995-05-04 | 2006-12-26 | Yale University | Recombinant vesiculoviruses and their uses |
US5690937A (en) * | 1995-06-05 | 1997-11-25 | Aviron | Temperature sensitive clustered changed-to-alanine mutants of influenza virus PB2 gene |
DE69510207T3 (de) | 1995-08-09 | 2007-02-15 | Schweiz. Serum- & Impfinstitut Bern | Verfahren zur Herstellung von infektiösen minussträngigen RNA-Viren |
JPH11512609A (ja) | 1995-09-27 | 1999-11-02 | アメリカ合衆国 | クローン化されたヌクレオチド配列からの感染性RSウイルス(respiratory syncytial virus)の生産 |
BR9710363A (pt) | 1996-07-15 | 2000-01-11 | Us Gov Health & Human Serv | "vìrus sincicial respirátorio recombinante infeccioso isolado, partìcula do mesmo, processos para estimular o sistema imunológico de um indivìduo para induzir proteção contra o vìrus sincicial respiratório e para produzir uma partìcula de vìrus sincicial respiratório recombinante, vacina para induzir proteção contra o vìrus sincicial respiratório recombinante composição e ceta de vìrus sincicial respiratório recombinante" |
KR20000048628A (ko) | 1996-09-27 | 2000-07-25 | 윌리암 에이취 캘넌, 에곤 이 버그 | 모노네가비랄레스 목의 바이러스에서 감쇠를 책임지는 3' 게놈프로모터 영역 및 폴리머라제 유전자 돌연변이 |
DE69842165D1 (de) | 1997-05-23 | 2011-04-21 | Us Of America As Represented By The Secretary Of The Dept Of Health And Human Services | Herstellung attenuierter parainfluenza-virus impfstoffe aus klonierten nukleotidsequenzen |
DK1012244T3 (da) | 1997-07-11 | 2007-09-10 | Univ Yale | Rhabdovira med genteknologisk manipulerede kapper |
US6946291B2 (en) * | 1998-04-24 | 2005-09-20 | University Hospitals Of Cleveland | Mixed cell diagnostic systems |
US6146642A (en) * | 1998-09-14 | 2000-11-14 | Mount Sinai School Of Medicine, Of The City University Of New York | Recombinant new castle disease virus RNA expression systems and vaccines |
US6544785B1 (en) * | 1998-09-14 | 2003-04-08 | Mount Sinai School Of Medicine Of New York University | Helper-free rescue of recombinant negative strand RNA viruses |
EP1194580B2 (en) | 1999-07-14 | 2010-08-25 | Mount Sinai School of Medicine of New York University | In vitro reconstitution of segmented negative-strand rna viruses |
ATE420189T1 (de) * | 2000-04-28 | 2009-01-15 | St Jude Childrens Res Hospital | Dna-transfektionssystem zur erzeugung von infektiösen negativsträngigen rna virus |
AU2001281967A1 (en) * | 2000-07-18 | 2002-01-30 | Bayer Aktiengesellschaft | Regulation of human desc1-like serine protease |
US20040241139A1 (en) * | 2000-07-20 | 2004-12-02 | Gerd Hobom | Recombinant influenza viruses with bicistronic vRNAs coding for two genes in tandem arrangement |
AU2003219745B8 (en) * | 2002-02-13 | 2008-10-09 | Wisconsin Alumni Research Foundation | Signal for packaging of influenza virus vectors |
AU2003230559B2 (en) * | 2002-02-21 | 2008-11-13 | Mount Sinai School Of Medicine | Recombinant negative strand virus RNA expression systems and vaccines |
US7465456B2 (en) * | 2002-04-26 | 2008-12-16 | Medimmune, Llc | Multi plasmid system for the production of influenza virus |
US7132523B2 (en) * | 2002-07-03 | 2006-11-07 | Ortho-Mcneil Pharmaceutical, Inc. | Human PRSS11-Like S2 serine protease and uses thereof |
KR20050052666A (ko) * | 2002-10-10 | 2005-06-03 | 다이버사 코포레이션 | 프로테아제, 이를 암호화하는 핵산, 및 이를 제조하고사용하는 방법 |
AU2004263813B8 (en) * | 2003-02-25 | 2008-09-11 | Medimmune, Llc | Methods of producing influenza vaccine compositions |
AU2004274860A1 (en) * | 2003-05-28 | 2005-03-31 | Wisconsin Alumni Research Foundation | Recombinant influenza vectors with a polII promoter and ribozymes |
US8475806B2 (en) | 2003-05-28 | 2013-07-02 | Wisconsin Alumni Research Foundation | High titer recombinant influenza viruses for vaccines and gene therapy |
EP1697521B1 (en) * | 2003-12-23 | 2010-06-02 | MedImmune, LLC | Multi plasmid system for the production of influenza virus |
MX2007007889A (es) * | 2004-12-24 | 2008-01-22 | Solvay Pharm Bv | Rescate del virus de influenza. |
US7790434B2 (en) * | 2005-06-21 | 2010-09-07 | Medimmune, Llc | Methods and compositions for expressing negative-sense viral RNA in canine cells |
EP1917352A4 (en) | 2005-06-21 | 2009-03-25 | Medimmune Vaccines Inc | METHODS AND COMPOSITIONS FOR EXPRESSING HETEROLOGOUS PROTEASE |
JP5491173B2 (ja) * | 2006-04-19 | 2014-05-14 | メディミューン,エルエルシー | イヌ細胞中でマイナス鎖ウイルスrnaを発現させるための方法および組成物 |
-
2006
- 2006-06-20 EP EP06773569A patent/EP1917352A4/en not_active Withdrawn
- 2006-06-20 WO PCT/US2006/023866 patent/WO2007002007A2/en active Application Filing
- 2006-06-20 BR BRPI0612268-0A patent/BRPI0612268A2/pt not_active IP Right Cessation
- 2006-06-20 AU AU2006262381A patent/AU2006262381A1/en not_active Abandoned
- 2006-06-20 KR KR1020087001669A patent/KR20080025171A/ko not_active Application Discontinuation
- 2006-06-20 WO PCT/US2006/023867 patent/WO2007002008A2/en active Application Filing
- 2006-06-20 KR KR1020087001609A patent/KR20080024212A/ko not_active Application Discontinuation
- 2006-06-20 JP JP2008518287A patent/JP2008543331A/ja active Pending
- 2006-06-20 CA CA002613284A patent/CA2613284A1/en not_active Abandoned
- 2006-06-20 EP EP06773570A patent/EP1917361A4/en not_active Withdrawn
- 2006-06-20 CA CA002613283A patent/CA2613283A1/en not_active Abandoned
- 2006-06-20 AU AU2006262380A patent/AU2006262380A1/en not_active Abandoned
- 2006-06-20 RU RU2008101367/13A patent/RU2008101367A/ru not_active Application Discontinuation
- 2006-06-20 US US11/455,734 patent/US20060286591A1/en not_active Abandoned
- 2006-06-20 JP JP2008518286A patent/JP2008546408A/ja active Pending
-
2007
- 2007-12-17 IL IL188202A patent/IL188202A0/en unknown
-
2008
- 2008-01-18 NO NO20080358A patent/NO20080358L/no not_active Application Discontinuation
-
2010
- 2010-02-17 US US12/706,994 patent/US20100203641A1/en not_active Abandoned
- 2010-07-23 US US12/842,854 patent/US8278433B2/en not_active Expired - Fee Related
-
2012
- 2012-08-31 US US13/601,401 patent/US8742089B2/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003091401A2 (en) * | 2002-04-26 | 2003-11-06 | Medimmune Vaccines, Inc. | Multi plasmid system for the production of influenza virus |
WO2004078912A2 (fr) * | 2003-02-28 | 2004-09-16 | Institut Pasteur | Promoteur de l’arn polymerase i de poulet et son utilisation |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2012527228A (ja) * | 2009-05-21 | 2012-11-08 | ノバルティス アーゲー | 非内因性polIプロモーターを使用した逆遺伝学 |
Also Published As
Publication number | Publication date |
---|---|
US20060286591A1 (en) | 2006-12-21 |
US20100203641A1 (en) | 2010-08-12 |
NO20080358L (no) | 2008-03-03 |
US8278433B2 (en) | 2012-10-02 |
BRPI0612268A2 (pt) | 2009-01-27 |
WO2007002008A3 (en) | 2007-12-27 |
EP1917361A2 (en) | 2008-05-07 |
CA2613284A1 (en) | 2007-01-04 |
AU2006262380A1 (en) | 2007-01-04 |
IL188202A0 (en) | 2008-03-20 |
EP1917352A2 (en) | 2008-05-07 |
US8742089B2 (en) | 2014-06-03 |
JP2008546408A (ja) | 2008-12-25 |
US20110045586A1 (en) | 2011-02-24 |
WO2007002007A3 (en) | 2007-06-21 |
KR20080024212A (ko) | 2008-03-17 |
EP1917352A4 (en) | 2009-03-25 |
US20120329150A1 (en) | 2012-12-27 |
CA2613283A1 (en) | 2007-01-04 |
KR20080025171A (ko) | 2008-03-19 |
WO2007002007A8 (en) | 2007-05-10 |
WO2007002008A2 (en) | 2007-01-04 |
WO2007002007A2 (en) | 2007-01-04 |
EP1917361A4 (en) | 2009-07-29 |
RU2008101367A (ru) | 2009-08-10 |
AU2006262381A1 (en) | 2007-01-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8742089B2 (en) | Methods and compositions for expressing negative-sense viral RNA in canine cells | |
JP5491173B2 (ja) | イヌ細胞中でマイナス鎖ウイルスrnaを発現させるための方法および組成物 | |
JP5303603B2 (ja) | インフルエンザウイルスの生産用多重プラスミドシステム | |
JP5264955B2 (ja) | インフルエンザウイルス作製のための多重プラスミド系 | |
US8097459B2 (en) | Methods and compositions for increasing replication capacity of an influenza virus | |
US7790434B2 (en) | Methods and compositions for expressing negative-sense viral RNA in canine cells | |
AU2013204811B2 (en) | Methods and compositions for expressing negative-sense viral rna in canine cells | |
CN101243189A (zh) | 用于在犬细胞内表达反义病毒rna的方法和组合物 | |
MX2008000245A (en) | Methods and compositionsfor expressing negative-sense viral rna in canine cells |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20090601 |
|
A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A712 Effective date: 20100521 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20111108 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20120410 |